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IMPORTANCE National guidelines do not agree on the role of carotid screening in

asymptomatic patients (ie, patients who have not had a stroke or transient ischemic attack).
Recently, several physician organizations participating in the Choosing Wisely campaign have
identified carotid imaging in selected asymptomatic populations as being of low value.
However, the majority of patients who are evaluated for carotid stenosis and subsequently
revascularized are asymptomatic.
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OBJECTIVE To better understand why asymptomatic patients who undergo revascularization

receive initial carotid imaging.
DESIGN, SETTING, AND PARTICIPANTS Retrospective cohort study of 4127 Veterans Health
Administration patients 65 years and older undergoing carotid revascularization for
asymptomatic carotid stenosis between 2005 and 2009.
MAIN OUTCOMES AND MEASURES Indications for carotid ultrasounds were extracted using
trained abstractors. Frequency of indications and appropriateness of initial carotid ultrasound
imaging for patients within each rating category after the intervention were reported.
RESULTS The mean (SD) age of this cohort of 4127 patients was 73.6 (5.9) years; 4014 (98.8%)
were male. Overall, there were 5226 indications for 4063 carotid ultrasounds. The most
common indications listed were carotid bruit (1578 [30.2% of indications]) and follow-up for
carotid disease (stenosis/history of carotid disease) in patients who had previously documented
carotid stenosis (1087 [20.8% of indications]). Multiple vascular risk factors were the next most
common indication listed. Rates of appropriate, uncertain, and inappropriate imaging were
5.4% (227 indications), 83.4% (3387 indications), and 11.3% (458 indications), respectively.
Among the most common inappropriate indications were dizziness/vertigo and syncope.
Among the 4063 patients, 3373 (83.0%) received a carotid endarterectomy. Overall, 663
procedures were performed in patients 80 years and older.
CONCLUSIONS AND RELEVANCE Carotid bruit and follow-up for carotid disease accounted
for approximately half of all indications provided by physicians for carotid testing. Strong
consideration should be given to improving the evidence base around carotid testing,
especially around monitoring stenosis over long periods and evaluating carotid bruits.
Targeting carotid ultrasound ordering with decision support tools may also be an important
step in reducing use of low-value imaging.
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Why Asymptomatic Patients Receive Carotid Imaging

S

troke is the fifth most common cause of death and is a
major cause of disability among US adults.1 Approximately 10% to 15% of ischemic strokes are attributable
to atherosclerosis of the carotid arteries.2 Secondary stroke prevention guidelines support the use of carotid imaging to evaluate patients with a recent cerebrovascular event to assess them
for carotid plaque.3 However, national guidelines conflict on
the role of carotid screening in asymptomatic populations (patients without a history of stroke or transient ischemic attack
[TIA]).4 For example, the US Preventive Services Task Force
(USPSTF) has recommended against carotid screening in adult
patients without a history of stroke or TIA in both its 2007 and
updated 2014 guidance.5 Other national guidelines favor
imaging for some limited indications in patients with asymptomatic carotid disease (eg, those with established stenosis,
carotid bruit, or multiple vascular risk factors) although these
recommendations are based on expert opinion rather than robust evidence.4,6
More recently, carotid imaging in asymptomatic populations has been identified by different physician specialty organizations as a low-value test and has appeared on several top
5 lists in the national “Choosing Wisely” campaign.7 The American Academy of Family Physicians,8 for example, has stated,
“don’t screen for carotid artery stenosis in asymptomatic
adults.” The American Academy of Neurology9 has stated,
“don’t perform imaging of the carotid arteries for simple syncope without other neurologic symptoms,” and the Society of
Thoracic Surgeons10 has stated, “don’t initiate routine evaluation of carotid artery disease prior to cardiac surgery in the
absence of symptoms or other high-risk criteria.”
Once imaging occurs in an asymptomatic patient, revascularization can be offered to patients with carotid stenosis
based on current guidelines for primary prevention of stroke.3
Embedded in these recommendations is an understanding derived from randomized clinical trials that patients undergoing revascularization are expected to live for at least 5 years
so that the short-term risks such as stroke, myocardial infarction, and death posed by the procedure are offset by the longterm benefits of stroke risk reduction.3,11 Although the evidence in support of efficacy of carotid revascularization to
reduce recurrent cerebrovascular events among patients with
symptomatic carotid disease is strong, the majority of revascularization procedures are performed in patients with asymptomatic carotid artery disease, in whom the evidence for clinical benefit is more modest and long-term outcomes are of
paramount importance.3,12,13 Therefore, ensuring that patients selected for revascularization will live long enough to
benefit is critical, and improving patient selection for carotid
imaging will ultimately improve the selection of revascularization recipients.
The long-term health consequences of low-value imaging
have not been commonly studied, and the risks and benefits
of diagnostic imaging are not always clear to patients and
clinicians. 1 4 To better understand why asymptomatic
patients receive carotid artery imaging, we examined the
indications provided by physicians for carotid ultrasounds in
a national cohort of patients who received carotid intervention for asymptomatic stenosis in the Veterans Health
jamainternalmedicine.com
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Key Points
Question Why do asymptomatic patients who undergo
revascularization receive initial carotid imaging?
Findings In this study of 4127 patients 65 years and older who
received carotid revascularization, the most common indications
provided by physicians for the initial carotid ultrasound were
carotid bruit and follow-up for carotid disease.
Meaning Consideration should be given to improving the
evidence base around carotid imaging.

Administration (VHA). Because guidelines recommend that
patients who receive revascularization have a 5-year life
expectancy, we also examined long-term survival of these
patients after the intervention.

Methods
Sample and Data Sources
This study was approved by the University of California, San
Francisco, Committee on Human Research. Informed consent was waived because this was a retrospective cohort study
with no human subject contact and minimal privacy risks.
Using national VHA data, we identified (N = 4127) patients 65
years and older undergoing carotid endarterectomy (CEA) and
carotid stenting (CAS) for asymptomatic carotid stenosis between 2005 and 2009. We defined asymptomatic patients as
patients who did not have evidence of any type of stroke or
TIA in the 6 months prior to receipt of first carotid imaging.
To identify asymptomatic patients, we used a previously developed high-sensitivity algorithm based on International Classification of Diseases, Ninth Revision, codes to exclude patients with stroke (including retinal artery occlusion) and TIA
using administrative data.15 We then reviewed each patient’s
medical record and further excluded any patient with any history of stroke and TIA documented in the medical record. We
examined the indication for the first carotid image each patient received in this period before revascularization. We intentionally looked for the first image in this period to reduce
the number of nonspecific indications provided such as “follow-up.” We limited the sample to carotid ultrasounds rather
than all imaging because other imaging modalities (eg, computed tomographic angiogram or magnetic resonance angiogram) may also be ordered to evaluate other vascular disease
and carotid findings may be incidental, whereas carotid ultrasound is used primarily to identify carotid stenosis. We used
national Veterans Affairs (VA) Corporate Data Warehouse and
VA Medical SAS administrative databases to obtain data on age,
sex, comorbidities, and CEA or CAS procedures.16 Medical record abstraction was used to confirm that CEA or CAS was performed after the first carotid image was obtained and to obtain additional data on comorbidities and indications listed by
physicians for carotid imaging. Long-term survival of the cohort of patients who underwent CEA and CAS was extracted
from the VA vital status file.16
(Reprinted) JAMA Internal Medicine May 2016 Volume 176, Number 5
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Table 1. Current National Guideline Recommendations on Carotid Imaging in Patients Without a History of Stroke or Transient Ischemic Attack (TIA)
Guideline

USPSTF5

ASA/AHA4

AIUM6

Screening for asymptomatic carotid artery stenosis in asymptomatic
adult (ie, someone without a history of TIA or stroke)

Not recommended

…

…

Routine screening of patients who have no clinical manifestations
of or risk factors for atherosclerosis

Not recommended

No benefit

…

Asymptomatic carotid bruit

Not recommended

Recommendation in favor of procedure being
useful based on diverging expert opinion, case
studies, or standard of care

Indicated

Follow-up of established carotid stenosis >50%

…

Recommendation in favor of procedure being
useful based on diverging expert opinion, case
studies, or standard of care

…

May be considered in asymptomatic patients with symptomatic
peripheral arterial disease, coronary artery disease, or
atherosclerotic aortic aneurysm

…

Recommendation’s usefulness/efficacy less well
established based on diverging expert opinion,
case studies, or standard of care

…

Might be considered to detect carotid stenosis in asymptomatic
patients without clinical evidence of atherosclerosis who have 2 or
more of the following risk factors: hypertension, hyperlipidemia,
tobacco smoking, family history in a first-degree relative of
atherosclerosis manifested before age 60 y, or a family history of
ischemic stroke

…

Recommendation’s usefulness/efficacy less well
established based on diverging expert opinion,
case studies, or standard of care

…

Not recommended for routine evaluation of patients with
neurological or psychiatric disorders unrelated to focal cerebral
ischemia, such as brain tumors, familial or degenerative cerebral or
motor neuron disorders, infectious and inflammatory conditions
affecting the brain, psychiatric disorders, or epilepsy

…

No benefit

…

Noninvasive imaging of the extracranial carotid arteries is reasonable
1 mo, 6 mo, and annually after revascularization to assess patency
and exclude the development of new or contralateral lesions. Once
stability has been established over an extended period, surveillance at
longer intervals may be appropriate. Termination of surveillance is
reasonable when the patient is no longer a candidate for intervention

…

Recommendation in favor of procedure being
useful based on diverging expert opinion,
case studies, or standard of care

Indicated

Carotid duplex ultrasound screening is reasonable before elective
coronary artery bypass graft surgery in patients older than 65 y
and in those with left main coronary stenosis, peripheral arterial
disease, a history of cigarette smoking, a history of stroke or TIA,
or carotid bruit

…

Recommendation in favor of procedure being
useful based on diverging expert opinion,
case studies, or standard of care

Indicated

Annual noninvasive imaging of the carotid arteries is reasonable
initially for patients with fibromuscular dysplasia to detect changes in
the extent or severity of disease, although the effect on outcomes is
unclear

…

Recommendation in favor of procedure being
useful based on diverging expert opinion,
case studies, or standard of care

…

Abbreviations: AHA, American Heart Association; AIUM, American Institute of Ultrasound Medicine; ASA, American Stroke Association; ellipses, no
recommendation; USPSTF, US Preventative Services Task Force.

Identification of Indication for Imaging
All indications for the initial carotid ultrasound were identified by 4 trained abstractors (A.W., A.A., R.A., S.S.). The abstractors were trained to review both the carotid report for indications listed by providers and the referring providers’ note.
Each carotid ultrasound could have multiple indications. If the
abstractors could not identify an indication based on these 2
sources of information or were unsure of the indication, 1 of 3
clinicians (S.K. [internist], E.M.C. [neurologist], A.N. [ophthalmologist]) reviewed the medical record and assigned an indication. If no indication was identified, then it was classified
as unknown and the patient was excluded from the sample.
If the indication was deemed to be unrelated to the carotid artery (eg, evaluation of a neck mass), the image was excluded
from the sample. The κ for agreement in indications from the
medical record for 2 reviewers for 2 separate samples of 20 carotid images was very good and ranged from 0.71 to 0.88.

Expert Panel Review of Indications
Expert review of indication was necessary because guideline
recommendations on screening in asymptomatic populations are limited and conflicting. Table 1 lists all the indications for which at least 1 national guideline has issued recom628

mendations. For example, some but not all guidelines
recommend screening for patients with carotid bruits.4 Given
the limited guidance available, we convened a multidisciplinary panel of practicing clinicians and stroke researchers including 3 internists (S.K., E.A.H., D.M.B.), 2 vascular neurologists (E.M.C., L.S.W.), 1 vascular surgeon (J. J.), and 2
ophthalmologists (S.R., A.N.) to review and rate the indications through a consensus process. Prior to the first meeting,
each panel member received a list of indications to be rated.
Panel members were instructed to rate each indication as appropriate, uncertain, or inappropriate based on a balance of risk
and benefit of imaging. The ratings were compiled and discussed among panel participants through 2 conference calls
with 1 caveat: the ocular indications were discussed and rated
separately by the ophthalmologists because many of the indications were based on eye examination findings not commonly encountered by other clinicians. Each indication was
then discussed by the group and a final rating was assigned on
the basis of consensus. The indication was rated as uncertain
if all raters deemed it uncertain or if consensus on appropriateness was not reached. We considered panel members as having agreement on ratings if all panel members agreed and disagreement if 1 or more panel members disagreed. Overall, there

JAMA Internal Medicine May 2016 Volume 176, Number 5 (Reprinted)
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was unanimity on 86.0% of the indications and disagreement on 14.0% of the indications. Among the uncertain indications, 50.0% were uncertain based on consensus and 50.0%
were rated uncertain because of disagreement among the panel
members.
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Table 2. Characteristics of Patients Who Received a Carotid Ultrasound
Between 2005 and 2009
Characteristic
Age, y

Analysis
First, we compared the indications abstracted from the medical record to currently available national guidelines to determine how well guidelines cover current practice. Second, we
compared the indications abstracted from the medical records to the quality assessments made by the expert panel. For
this analysis, the sample was restricted to the 4063 patients
whose carotid ultrasound had at least 1 indication listed. If the
ultrasound had multiple indications, the rating of the test was
assigned on the basis of the most appropriate indication(s). We
calculated percentages of carotid ultrasounds rated appropriate, uncertain, or inappropriate. Finally, we also compared
5-year overall survival in patients receiving carotid imaging and
subsequent medical record–confirmed revascularization
among the 3 appropriateness categories using a log-rank test.
Analyses were conducted using SAS, version 9.4 (SAS Institute), and Stata, version 12.1.

Results
Patient Characteristics
A total of 4127 patients were in the cohort; 64 patients had no
indications provided by clinicians, leaving a final sample of
4063 patients (Table 2). The mean (SD) age of this cohort was
73.6 (5.9) years; 4014 (98.8%) were male. Comorbidities were
common and included hypertension (3583 [88.2%]), diabetes mellitus (1607 [39.6%]), and atrial fibrillation (442 [10.9%]).
The majority of patients received CEA (3373 [83.0%]), while
684 (16.8%) received CAS, and 6 patients (0.1%) did not have
a medical record–confirmed revascularization within 5 years
after first carotid image.

No. (%)
(N = 4063)

65 to 74

2467 (60.7)

75 to 84

1472 (36.2)

≥85

124 (3.1)

Male sex

4014 (98.8)

Comorbidity
Hypertension

3583 (88.2)

Hyperlipidemia

3167 (77.9)

Diabetes mellitus

1607 (39.6)

Atrial fibrillation

442 (10.9)

Coronary artery disease

2019 (49.7)

Peripheral vascular disease

1107 (27.2)

Congestive heart failure

288 (7.1)

Chronic obstructive pulmonary disease

798 (19.6)

Procedurea

a

Carotid endarterectomy

3373 (83.0)

Carotid artery stenting

684 (16.8)

Medical record review revealed that 6 patients did not receive subsequent
intervention.

for carotid disease (stenosis/history of carotid disease) in a patient who had previously documented carotid stenosis was the
second most common indication (1087 [20.8%] of 5226 indications). Carotid bruit and follow-up for carotid disease accounted for half (2677 [51.2%] of 5226 indications) of all indications. Multiple vascular risk factors were the next most
common indication listed. Overall, currently available national guidelines shown in Table 1 covered 3593 (68.7%) of the
indications extracted from this national cohort. The most common areas not covered by guidelines included syncope, dizziness/vertigo, remote history of stroke or TIA, and preoperative evaluation.

Appropriateness of Carotid Imaging
Frequency and Type of Indications
Overall, there were 5226 indications for 4063 carotid ultrasounds in 4063 patients. Approximately 3062 (75.4%) carotid ultrasounds had a single indication while the remaining
(n = 1001) had multiple indications. Fifty-seven unique indications were identified. Among these 57 indications, 32 (56%)
were listed 10 or more times and 11 (19%) were listed only once.
Table 3 provides the entire list of indications grouped by clinical themes identified. Overall, there were 6 main clinical
themes for ordering carotid images in asymptomatic populations that emerged: (1) vascular indications, (2) near-syncope/
syncope indications, (3) neuropsychiatric indications, (4) earrelated indications, (5) ocular indications, and (6) imaging as
part of a preoperative evaluation. There were also some isolated indications presented in the “other” category that were
uncommon (<1% of all indications) and could not be clinically grouped. The most common indication listed was carotid bruit, which accounted for approximately one-third of
all indications (1578 [30.2%] of 5226 indications). Follow-up
jamainternalmedicine.com

Each indication was rated using the expert panel’s assessment. The majority of images (3421 [84.2%]) had a single indication, while the remaining images had between 2 and 4 indications. A total of 398 (9.8%) images had multiple indications
with different levels of appropriateness. We assigned each image the most appropriate quality assessment. Some carotid ultrasounds had multiple indications with the same quality assessments (eg, 2 indications that were both appropriate). Rates
of appropriate, uncertain, and inappropriate imaging were 5.4%
(227 indications), 83.4% (3387 indications), and 11.3% (458 indications), respectively (Table 4). Whereas most of the appropriate indications assigned to images were related to ocular disease (164 [72.2%] of 227), the most common appropriate
indication listed was follow-up within 2 years of carotid intervention. Carotid bruit and follow-up for established carotid disease were the most prevalent uncertain indications.
Among the inappropriate indications, dizziness/vertigo, syncope, and blurred/change in vision were the most common
(Table 3).
(Reprinted) JAMA Internal Medicine May 2016 Volume 176, Number 5
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Table 3. The 57 Unique Indications Grouped by Clinical Theme (N = 5226)
All Indications, No. (%)
Vascular

Near-Syncope/
Syncope

Eye Related

Preoperative
Evaluation

Neurological/
Psychological

Other

3881 (74.2)

568 (10.8)

351 (6.7)

239 (4.5)

117 (2.2)

50 (0.94)

21 (0.40)

Carotid bruit, n = 1578
Stenosis/history of carotid
disease, n = 1099
Hypertension with another
vascular risk factor, n = 505
History of stroke/TIA >6 mo,
n = 199
Follow-up after CEA/CAS >2 y,
n = 175
Old stroke/silent stroke found on
neuroimaging, n = 95
Carotid calcification/finding on
x-ray or other image, n = 80
Follow-up after CEA/CAS <2 y,
n = 63
Suspected carotid disease,
n = 44
Smoking history with another
vascular risk factor, n = 35
Decreased carotid pulse, n = 5
No palpable carotid pulse, n = 2
Family history of
cerebrovascular accident, n = 1

Dizziness/
vertigo, n = 388
Syncope,
n = 147
Lightheadedness, n = 22
Orthostatic
hypotension,
n = 11

Blurred vision/change in
vision, n = 124
Multiple unilateral peripheral
retinal hemorrhage, n = 36
Single unilateral peripheral
retinal hemorrhage, n = 28
Hollenhorst plaque/eye
plaque, n = 59
Ocular ischemic syndrome,
n = 38
Asymmetrical intraocular
pressure, n = 1
Asymmetrical retinopathy,
n = 30
Branch retinal vein occlusion,
n = 13
Optic nerve ischemia, n = 9
Diplopia, n = 5
Anterior ischemic optic
neuropathy, n = 3
Sequential disk swelling, n = 1
Cotton wool spot, n = 1
Occasional dark spot in visual
field, n = 1
Optic nerve changes, n = 1
Cystoid macular edema,
n=1

Other surgical
procedures,
n = 146
CABG, n = 93

Memory loss or
dementia, n = 32
Fall (without focal
weakness), n = 26
Tilting/change in gait
(without focal
weakness), n = 11
Balance problems
(without focal
weakness), n = 10
Seizure, n = 8
Tingling sensation of
body part without
other neurologic
deficit, n = 7
Nonfocal peripheral
neuropathy, n = 7
Tremor, n = 6
Mental status change,
n=5
Staggering (without
focal weakness),
n=4
Tingling sensation
with elevation of
head, n = 1

Headache,
n = 17
Generalized
weakness,
n = 16
Neck pain,
n = 10
Chest pain,
n=2
Cardiac murmur
radiating to
neck, n = 2
Jaw pain, n = 2
Dyspnea, n = 1

Pulsation in
ears, n = 14
Tinnitus,
n=5
Ringing
above ear,
n=1
Ear tingling,
n=1

Ear Related

Abbreviations: CABG, coronary artery bypass graft; CAS, carotid stenting; CEA, carotid endarterectomy; TIA, transient ischemic attack.

Table 4. Expert Panel Rating and Frequency of Indications Per Ultrasound (4774 Indications for 4063 Images)
Patients, No. (%)
Appropriate Indicationsa
(n = 227)

Uncertain Indicationsa
(n = 4028)

218 (5.4)

3387 (83.4)

458 (11.3)

Follow-up after CEA/CAS <2 y, n = 63
Hollenhorst plaque, plaque in eye, n = 59
Ocular ischemic syndrome, n = 38
Multiple unilateral peripheral retinal
hemorrhages, n = 36
Eye findings suggestive of ocular ischemic
syndrome (eg, asymmetrical intraocular
pressure), n = 1
Asymmetrical retinopathy, n = 30

Carotid bruit, n = 1572
Follow-up for stenosis/history carotid disease,
n = 1073
Hypertension with 1 other vascular risk factor,
n = 500
History of stroke/transient ischemic attack
>6 mo, n = 194
Follow-up after CEA/CAS (>2 y), n = 172
Preoperative evaluation, n = 145
Old stroke/silent stroke found on
neuroimaging, n = 93
CABG workup, n = 92
Carotid calcification or finding on x-ray
or other image, n = 79
Suspected carotid disease/rule out carotid
disease, n = 41
Smoking history with other risk factor, n = 35
Pulsation in ears, n = 14
Neck pain, n = 9
Decreased carotid pulse, n = 5
Cardiac murmur radiating to neck, n = 2
No palpable carotid pulse, n = 2

Dizziness/vertigo, n = 209
Syncope, n = 100
Blurred vision/change in vision, n = 70
Single peripheral retinal hemorrhage, n = 19
Memory loss or dementia, n = 13
Lightheadedness, n = 12
Fall without focal weakness, n = 9
Headache, n = 9
Optic nerve ischemia, n = 8
Branch retinal vein occlusion, n = 7
Generalized weakness, n = 7
Orthostatic hypotension, n = 7
Tilting/change in gait (without focal weakness), n = 7
Tingling of limb without focal weakness, n = 6
Balance problems without focal weakness, n = 5
Seizures, n = 5
Tremor, n = 4
Anterior ischemic optic neuropathy, n = 3
Diplopia, n = 3
Mental status change, n = 2
Nonfocal peripheral neuropathy, n = 2
Tinnitus, n = 2
Cotton wool spot, n = 1
Cystoid macular edema, n = 1
Dyspnea, n = 1
Family history of cerebrovascular accident, n = 1
Jaw pain, n = 1
Occasional dark spot in visual field, n = 1
Optic nerve changes, n = 1
Sequential disk swelling, n = 1
Staggering (without focal weakness), n = 1
Tingling with elevation of head, n = 1

Abbreviations: CABG, coronary artery bypass graft; CAS, carotid stenting;
CEA, carotid endarterectomy.
a

630

Inappropriate Indicationsa
(n = 519)

If an image had multiple indications, the indication that was most appropriate

was listed in Table 3; therefore, there are fewer indications than were listed in
Table 2. Patients could have multiple appropriate indications, multiple
uncertain indications, and multiple inappropriate indications.

JAMA Internal Medicine May 2016 Volume 176, Number 5 (Reprinted)
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Long-term Survival
Among the 4063 patients in the final sample, 3373 (83.0%) received a CEA. Overall, 663 procedures were performed in patients 80 years and older. Postintervention overall survival in
this cohort was 71.4% at 5 years. Rates of survival by age group
65 to 74, 75 to 84, and 85 years and older were 75.3% (1857 patients), 66.5% (979 patients), and 58.9% (73 patients), respectively (P < .001). Rates of survival among patients who received carotid imaging on the basis of appropriate, uncertain,
and inappropriate indications were not significantly different (P = .07) and were 66.4%, 72.1%, and 68.8%, respectively.

Discussion
Most carotid imaging tests that resulted in patients with asymptomatic carotid disease undergoing revascularization were performed for indications in which the benefits of imaging are uncertain, and 1 in 9 tests were performed for inappropriate
indications. We found that approximately one-third of indications listed by clinicians are not addressed by current national guidelines. We also found that many patients do not live
long enough to benefit from revascularization.
There is a tension between appropriate screening and appropriate revascularization that necessitates further comment. It is possible that a patient would be screened on the basis of an indication that would appear clinically inappropriate
for imaging but lead to an otherwise appropriate revascularization procedure if severe stenosis was identified. This clinical dilemma is the result of the chosen point of reference. From
an individual perspective, it may be beneficial to have screening that is not guideline based if that screening demonstrates
a true positive abnormality that is amenable to an effective evidence-based intervention. From a societal perspective, screening all patients (including a patient who benefited) may not be
beneficial (and thus not recommended) if the false-positive rate
of the screening test is high or the evidence for intervention
is weak. This tension between the individual perspective
(which often does not include consideration of the harms of
false-positive test results) and the societal perspective is at the
root of many of the current national debates on screening.
In the case of carotid disease, the tension between the
individual and population perspective is further exacerbated
by the fact that different societies have different recommendations based on how they define an “asymptomatic”
individual. 4,5 A patient with vascular disease may have
asymptomatic carotid disease (ie, no history of stroke or TIA),
but by virtue of the presence of systemic atherosclerosis, the
American Heart Association considers it reasonable to screen
such patients, whereas the USPSTF does not.
Other areas in which national recommendations differ include further assessment of a carotid bruit. In our study, greater
than half of all imaging was performed to evaluate for carotid
bruit and monitor the progression of carotid stenosis, indications that our panel rated as of uncertain value because of a
lack of evidence in the area. For example, a patient with a carotid bruit who is of advanced age and has multiple comorbidities may have little clinical benefit from imaging. Such a
jamainternalmedicine.com
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patient may not live long enough to benefit from intervention. Another area in which improved guidance is necessary
relates to the duration of follow-up imaging for patients with
established carotid stenosis. The USPSTF has an overall recommendation against any screening in asymptomatic carotid populations, whereas the guidelines issued by the American Heart Association in conjunction with other specialty
societies recommend screening and follow-up for carotid disease in patients with carotid bruit and also patients with greater
than 50% stenosis.4 Revisiting the evidence base and clarifying, expanding, and harmonizing the guidelines for imaging
in asymptomatic populations may be warranted to reduce potentially unnecessary testing.
The 2 most recent major randomized clinical trials of intervention in asymptomatic patients showed that given the procedural risks inherent in CEA and CAS procedures, patients must
live 5 years to realize a net benefit from revascularization.3,17,18
Roughly one-quarter of the patients in our cohort who received intervention did not survive 5 years. This was more than
double the death rate observed in the most recent trial.17,19 The
fact that long-term survival was similar for patients who received imaging for indications deemed appropriate or uncertain vs inappropriate imaging deserves some comment. Revascularization once carotid stenosis is identified may occur
without full consideration of a patient’s life expectancy. Although patient reassurance, clinician uncertainty, and other reasons might underlie test ordering regardless of patient eligibility, these findings could suggest that guideline development
and decision support for carotid imaging ordering in an asymptomatic patient should more fully address eligibility for intervention at the time of initial test ordering.
Our results also suggest that reducing inappropriate carotid imaging may stem a “pipeline” of low-value care because many patients who were subsequently revascularized
received initial imaging for reasons considered inappropriate
by our expert panel. Reducing low-value carotid imaging can
also reduce low-value carotid intervention in patients who will
not live long enough to benefit. Given that carotid imaging is
a fairly commonly ordered test, targeting carotid imaging using
decision support tools to reduce inappropriate use may be a
good approach to improve the value of health care without
compromising quality. Currently there is no guidance on ordering carotid ultrasound in the VHA or in most clinical settings. Our study demonstrates that developing such decision
support is needed.
The sample chosen for this study has both strengths and
limitations. On the one hand, this cohort focuses on asymptomatic patients who underwent revascularization and does
not represent all patients who receive carotid imaging. The distribution of indications may be different in a population that
did not receive intervention. On the other hand, our cohort is
an important sample to examine because it provides an assessment of the primary reason for screening for carotid stenosis among patients who ultimately received intervention.
The long-term consequence of this pipeline of low-value care
is more apparent. Another important limitation to consider is
the generalizability of the sample. The indications extracted
were for carotid ultrasounds ordered by physicians practic(Reprinted) JAMA Internal Medicine May 2016 Volume 176, Number 5
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ing in the VHA, a national setting with an electronic health record and electronic ordering system. Our results may not represent the scope of indications for which physicians order
carotid imaging in different settings. However, most VHA hospitals have academic affiliations and many clinicians practice
in multiple settings; therefore, it is likely that our results are
representative of academic settings with electronic imaging
ordering. Another limitation is that our cohort was almost
entirely male; however, there is no reason to believe that
indications listed by physicians for imaging would vary by sex.
In addition, appropriateness assessment by the expert panel
was by full consensus and any disagreement resulted in a quality assessment of “uncertain.” Our conservative approach with
a requirement of 100% agreement among panel members on
indications resulted in more quality assessments being assigned an “uncertain” rating than an “inappropriate” rating.
However, a slight shift in the quality assessments from uncertain to inappropriate would not materially affect our conclusions. Finally, the indications extracted were for the period of
2005 to 2009; it is possible that reasons for ordering carotid
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images have evolved. However, national guidelines currently
still conflict.4,5

Conclusions
The majority of patients who undergo carotid revascularization
for asymptomatic carotid disease received a diagnosis on the basis of results of tests ordered for uncertain or inappropriate reasons. Consideration should be given to improving the evidence
base around carotid testing, especially around monitoring stenosis over long periods and evaluating carotid bruits. The ongoing National Institutes of Health–sponsored Carotid Revascularization and Medical Management for Asymptomatic Carotid
Stenosis Trial (CREST-2) should clarify the value of revascularization in asymptomatic populations.20 Finally, clarifying and
harmonizing current guidelines and the development of evidence-based decision support tools to support appropriate patient selection for carotid imaging in practice can reduce the use
of low-value imaging and improve long-term patient outcomes.
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Invited Commentary

Screening for Asymptomatic Carotid Artery Stenosis
Evidence-Based Opinion
Larry B. Goldstein, MD

Evidence-based medicine is a linchpin of contemporary clinical practice. It requires “the integration of the best research evidence with clinical expertise and the patient’s unique values and
circumstances.”1(p1) The task can be daunting for busy clinicians, leading to the development of a plethora of clinical
Author Audio Interview at
guidelines intended to projamainternalmedicine.com
vide recommendations aimed
at optimizing patient care by
Related article page 626
summarizing and evaluating
the available evidence supporting or refuting the use of diagnostic studies or therapeutic approaches. As of January 2016,
the US Agency for Healthcare Research and Quality listed 3348
guidelines related to diseases or conditions, 8163 addressing
treatments or interventions, and 1203 focused on health services administration.2 As with the underlying research itself,
however, clinical practice guidelines can vary in quality, which
led to efforts to set standards to ensure their value.3(pp75-107)
For any given problem, different professional societies, and
indeed panels within single societies, can disagree on recommendations. Because the framing of clinical questions and the
implications and interpretation of the underlying data may vary
depending on context and other factors, guideline recommendations on a specific issue may differ in minor or substantial
ways among different statements. Depending on when they
were written and other factors, these documents can lack uniformity. There are a myriad of other potential reasons for the
disparities among guidelines, which can then understandably lead to considerable uncertainty and variability in clinical practice.
Against this background, Keyhani et al4 evaluated screening for asymptomatic stenosis of the extracranial carotid arjamainternalmedicine.com

tery. The authors noted that although there are several relevant guidelines, the recommendations lack consistency. For
example, the American Institute of Ultrasound Medicine concluded that carotid artery screening is indicated for patients
with a carotid bruit whereas the US Preventive Services Task
Force (USPSTF) states that the procedure is not recommended in this setting. Table 1 of Keyhani et al4 gives the similarities and differences between these 2 sets of guidelines and
recommendations from the American Heart Association/
American Stroke Association (AHA/ASA) and collaborating
organizations.
It is notable that both the USPSTF and the AHA/ASA guidelines agree that there is no benefit for routine screening of populations with no clinical manifestations or risk factors for atherosclerosis. With an estimated population attributable risk of
carotid stenosis for stroke in those older than 60 years of 0.9%,
the prevalence of asymptomatic carotid stenosis would need
to be 14 times greater to reach a level similar to hyperlipidemia and more than 100 times greater to carry a risk similar
to hypertension.5 The USPSTF found no validated risk stratification tool or physical finding, including the presence of a
cervical bruit, that was useful for identifying those who do or
do not have a clinically important asymptomatic carotid artery stenosis.6 Yet such screenings are offered in a variety of
settings.5
Screening for a disease or condition is rational only if its
identification has a meaningful effect on patient management. Epidemiological studies conducted over the last 3 decades such as the Evans County, Georgia, study find that an
anterior cervical bruit is an indicator of generalized atherosclerosis and is a greater risk factor for death due to coronary
heart disease than stroke.7 In the Evans County, Georgia, study,
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